Back to Results
First PageMeta Content
Pharmaceuticals policy / Gilead Sciences / Pharmaceutical industry / Generic drug / Pharmasset / Food and Drug Administration / Merck & Co. / Gilead / Pharmaceutical sciences / Pharmacology / Clinical research


Microsoft Word - H0041724.DOCX
Add to Reading List

Document Date: 2015-01-26 12:19:15


Open Document

File Size: 499,04 KB

Share Result on Facebook

Company

Merck & Co Inc. / GILEAD SCIENCES INC. / AbbVie Inc. / Idenix Pharmaceuticals Inc. / H0041724 / Prime Therapeutics LLC / Public Citizen / Aetna / CVS / Pharmaceutical Business Research Associates / Pharmasset Inc. / Defendant Gilead Sciences Inc. / Anthem / Express Scripts / /

Country

Egypt / France / United States / India / /

Currency

USD / /

/

Event

Business Partnership / FDA Phase / M&A / Earnings Announcement / /

IndustryTerm

distribution chain / strict protocols / food / insurance coverage / healthcare coverage / healthcare system / consumer advocacy / Hepatitis C treatment / /

MedicalCondition

Epidemic / Hepatitis C / another Hepatitis C / chronic genotype infection / infections / disease / certain Hepatitis C / HCV / /

Organization

National Institute of Health / Food and Drug Administration / Department of Veteran Affairs / Bureau of Prisons / EASTERN DISTRICT OF PENNSYLVANIA SOUTHEASTERN PENNSYLVANIA TRANSPORTATION AUTHORITY / Internal Revenue Service / Plaintiffs Southeastern Pennsylvania Transportation Authority / National Association of Medicaid Directors / federal government / Senate Finance Committee / FDA / Haverford Centre / /

Person

JOHN DOE / Steve Miller / Matt Salo / Robert Weissman / Daniel Hoffman / Benjamin F. Johns Joseph / Nicholas E. Chimicles Benjamin / /

/

Position

counsel / Executive Director / president / chief medical officer / /

Product

Sovaldi tablet / Patent Application / Sovaldi / ribavirin / Harvoni / Harvoni 90 mg / Acquisition / /

Region

SOUTHEASTERN PENNSYLVANIA / /

Technology

genotype / /

SocialTag